Sarah Williams
NovaBay Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Breastfeeding Practices and Influences, Infant Development and Preterm Care, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Antibiotic Resistance in Bacteria
Most-Cited Works
- → Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases(2016)909 cited
- → Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor(2016)286 cited
- → Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer(2020)210 cited
- → Dual Allosteric Inhibition of SHP2 Phosphatase(2018)127 cited
- Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action.(2002)
- → 6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors(2019)86 cited
- → Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors(2020)70 cited
- → Are the benefits of a high‐intensity progressive resistance training program sustained in rheumatoid arthritis patients? A 3‐year followup study(2011)52 cited
- → The translocation kinetics of antibiotics through porin OmpC: Insights from structure‐based solvation mapping using WaterMap(2012)50 cited
- → Antioxidant Requirements of Endurance Athletes: Implications for Health(2006)42 cited